We recently proposed the concept of tumour effector functions. The tumour-supportive properties
the ‘onco-regenerative niche’ (ORN) [6], suggesting that cell of TAM, which have established roles in promoting cell
death in tumours provides a central driving force in shaping growth, angiogenesis and matrix remodelling, while at the
the tumour microenvironment by orchestrating a series of same time suppressing anti-tumour immune responses, are
interconnected cellular responses and extracellular modifi- reminiscent of the properties of macrophages that are driven
cations that promote tumour growth, progression and by their interaction with apoptotic cells [6,13]. In fact, apoptotic
relapse. The ORN, its constituent key cells, molecules and cells are drivers of M2-like activation of macrophages [80] and
activities, is a ‘skeletal’ concept at present, serving as a frame- impose dominant effects on M1 macrophages, potently sup-
work for improving our understanding of the broad pressing their anti-tumour activity [81]. The ‘M1-suppressive’
implications of cell death in tumours, be it constitutive as property of apoptosis has serious implications for tumour
part of cancer pathogenesis, or induced as a consequence of repopulation post therapy and suggests that the very apoptosis
therapy.